Cargando…
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the first documented pandemic due to a coronavirus that continues to be a major health challenge. Despite being rapid, uncontrollable, and highly infectious in its spread, it also created incentives for technolo...
Autores principales: | Gupta, Yash, Savytskyi, Oleksandr V., Coban, Matt, Venugopal, Amoghavarsha, Pleqi, Vasili, Weber, Caleb A., Chitale, Rohit, Durvasula, Ravi, Hopkins, Christopher, Kempaiah, Prakasha, Caulfield, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613808/ https://www.ncbi.nlm.nih.gov/pubmed/36371228 http://dx.doi.org/10.1016/j.mam.2022.101151 |
Ejemplares similares
-
In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity
por: Mohammad, Thahani S. Habeeb, et al.
Publicado: (2023) -
Repurposing Lansoprazole and Posaconazole to treat leishmaniasis: Integration of in vitro testing, pharmacological corroboration, and mechanisms of action
por: Gupta, Yash, et al.
Publicado: (2022) -
Mycolactone: A Broad Spectrum Multitarget Antiviral Active in the Picomolar Range for COVID-19 Prevention and Cure
por: Asiedu, Seth Osei, et al.
Publicado: (2023) -
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy
por: Gupta, Yash, et al.
Publicado: (2021) -
A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
por: Maciorowski, Dawid, et al.
Publicado: (2020)